| Aurobindo Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524804 |
NSE Symbol : AUROPHARMA |
P/E(TTM) : 47.17 |
|
ISIN Demat : INE406A01037 |
Div & Yield% : 0.29 |
EPS(TTM) : 32.62 |
|
Book Value(₹) : 336.60 |
Market Cap(₹Cr) : 90,161.30 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,425.22 | 2,866.40 | 2,663.87 | 2,648.41 | 2,363.53 | 2,371.73 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,425.22 | 2,866.40 | 2,663.87 | 2,648.41 | 2,363.53 | 2,371.73 |
| Other Operating Income | 34.87 | 27.63 | 28.16 | 20.35 | 27.29 | 34.50 |
| Other Income | 65.32 | 122.97 | 331.13 | 103.17 | 113.29 | 326.48 |
| Total Income | 2,525.41 | 3,017.00 | 3,023.16 | 2,771.93 | 2,504.11 | 2,732.71 |
| Total Expenditure | 1,961.16 | 2,119.24 | 2,210.34 | 2,123.58 | 1,968.50 | 1,830.31 |
| PBIDT | 564.25 | 897.76 | 812.82 | 648.35 | 535.61 | 902.40 |
| Interest | 51.13 | 53.07 | 61.25 | 36.69 | 31.59 | 31.77 |
| PBDT | 513.12 | 844.69 | 751.57 | 611.66 | 504.02 | 870.63 |
| Depreciation | 66.88 | 64.81 | 64.35 | 65.79 | 59.63 | 66.68 |
| Tax | 119.66 | 207.66 | 136.95 | 137.17 | 116.38 | 161.40 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.46 | -6.45 | -73.51 | -7.04 | -8.26 | -2.42 |
| Reported Profit After Tax | 329.04 | 578.67 | 623.78 | 415.74 | 336.27 | 644.97 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 36.09 | 17.95 | 46.29 |
| Adjusted Profit After Extra-ordinary item | 329.04 | 578.67 | 623.78 | 379.65 | 318.32 | 598.68 |
| EPS (Unit Curr.) | 5.62 | 9.88 | 10.65 | 7.10 | 5.74 | 11.00 |
| EPS (Adj) (Unit Curr.) | 5.62 | 9.88 | 10.65 | 7.10 | 5.74 | 11.00 |
| Calculated EPS (Unit Curr.) | 5.62 | 9.88 | 10.65 | 7.10 | 5.74 | 11.01 |
| Calculated EPS (Adj) (Unit Curr.) | 5.62 | 9.88 | 10.65 | 7.10 | 5.74 | 11.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 22.46 | 39.51 | 42.59 | 28.38 | 22.96 | 44.03 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 22.46 | 39.51 | 42.59 | 28.38 | 22.96 | 44.03 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 150.00 | 0.00 | 0.00 | 0.00 |
| Equity | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.27 | 31.32 | 30.51 | 24.48 | 22.66 | 38.05 |
| PBDTM(%) | 21.16 | 29.47 | 28.21 | 23.10 | 21.32 | 36.71 |
| PATM(%) | 13.57 | 20.19 | 23.42 | 15.70 | 14.23 | 27.19 |